Health Canada approves skin cancer device from Sensus

11/27/2012 | (Boston)

Health Canada has given Sensus Healthcare the go-ahead to market its SRT-100 system in that country. The device, tailored for use in hospitals and private physician practices, is designed to treat patients with non-melanoma skin cancer without the need for surgery.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations